Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Some skin diseases and their treatments can negatively affect male fertility.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

Large language models often give biased or inaccurate medical responses, especially for LGBTQIA+ prompts.

AR gene variations don't affect aging markers in men.

Mentha spicata leaves lower testosterone and aggression in female rats.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

PCOS has no cure, but treatments can manage symptoms and improve health.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Histone demethylases can change gene expression and may be linked to diseases like cancer.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Water near Abakaliki mines has high toxic metal levels, posing health risks.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgens can both increase and decrease hair growth in different parts of the body.